Key takeaway
What This Development Means
Bündnis für eine enkeltaugliche Landwirtschaft eV has filed a legal action against the European Commission, disputing the extension of Fluopyram's approval under Regulation (EC) No 1107/2009. The group claims procedural violations, environmental risk neglect, and unjustified extension periods.
What is the legal basis for challenging the Fluopyram extension?
The applicant alleges misinterpretations of Regulation (EC) No 1107/2009, specifically concerning procedural deadlines, environmental risks, and the duration of the approval extension.
Why is Fluopyram's extension controversial?
Fluopyram's extended approval has raised concerns due to its potential health and environmental impacts, which critics argue were not adequately considered by the Commission.
The Bündnis für eine enkeltaugliche Landwirtschaft eV has filed an action at the General Court of the European Union on 8 November 2024, contesting the European Commission's decision to extend the approval period for the active substance Fluopyram. The group alleges regulatory misinterpretation, environmental risk negligence, and an excessive extension period.
Legal Basis And Claims
The action, brought by Bündnis für eine enkeltaugliche Landwirtschaft eV, seeks the annulment of the Commission's decision dated 15 August 2024. The applicant contends that the decision violates Regulation (EC) No 1107/2009, which governs the approval of plant protection substances. Specifically, they argue:
Misinterpretation of Regulation Article 17: The Commission allegedly failed to adhere to procedural time limits established by Regulation (EU) No 844/2012.Neglecting Risks to Health and Environment: Extending Fluopyram's approval allegedly disregards risks identified during its assessment.Excessive Extension Period: The applicant claims the extension exceeded the necessary duration to complete the review.
Background On Fluopyram Extension
Fluopyram, an active substance used in agricultural fungicides, had its approval extended under Implementing Regulation 2024/324 on 19 January 2024. The Commission extended approval periods for multiple substances to allow sufficient time for regulatory reviews.
Broader Implications
The outcome of this case could influence future decisions regarding active substances under Regulation (EC) No 1107/2009, balancing procedural efficiency with health and environmental safeguards.
This legal challenge underscores the tension between regulatory adherence and environmental responsibility within the EU’s chemical approval processes. A decision is pending from the General Court, which will assess the validity of the applicant’s claims.
Related Articles
ClientEarth v European Commission Reinforces Transparency Rules On Mancozeb And Cypermethrin Decisions
ClientEarth v European Commission confirms that the Commission must justify refusals to disclose pesticide-related documents with specific evidence. While reinforcing transparency around mancozeb and cypermethrin decision-making, the ruling preserves important limits where disclosure could undermine court proceedings, signalling a more balanced but stricter application of EU access-to-documents rules.
EU Publishes Draft Plant Protection Products Labelling Regulation
The EU invites feedback on the updated plant protection product labelling regulation until 3 February 2025. Share your views to shape the final regulation.
European Commission's Appeal On EFSA Guidance Document Access Denied
EU Court dismisses Commission's appeal, ensuring public access to EFSA's plant protection guidance.
